MIG
ARKG icon

McGuire Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

McGuire Investment Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,491
Closed -$541K – 138
2026
Q1 		$541K Buy
20,491
+193
+1% +$5.65K 0.06% 93
2025
Q4 		$588K Buy
20,298
+1,246
+7% +$37.4K 0.06% 88
2025
Q3 		$529K Hold
19,052
– – 0.06% 90
2025
Q2 		$464K Sell
19,052
-1,000
-5% -$21.9K 0.06% 90
2025
Q1 		$416K Buy
20,052
+8,432
+73% +$212K 0.06% 88
2024
Q4 		$274K Sell
11,620
-5,946
-34% -$146K 0.04% 99
2024
Q3 		$450K Sell
17,566
-3,971
-18% -$101K 0.06% 88
2024
Q2 		$506K Sell
21,537
-21
-0.1% -$530 0.07% 81
2024
Q1 		$620K Buy
21,558
+1,000
+5% +$30.1K 0.09% 80
2023
Q4 		$675K Buy
20,558
+9,792
+91% +$266K 0.11% 73
2023
Q3 		$300K Sell
10,766
-886
-8% -$29K 0.06% 90
2023
Q2 		$397K Sell
11,652
-16,527
-59% -$519K 0.07% 84
2023
Q1 		$847K Sell
28,179
-4,474
-14% -$139K 0.17% 70
2022
Q4 		$922K Sell
32,653
-7,772
-19% -$247K 0.2% 64
2022
Q3 		$1.33M Buy
40,425
+4,931
+14% +$181K 0.3% 58
2022
Q2 		$1.12M Sell
35,494
-687
-2% -$24K 0.24% 61
2022
Q1 		$1.66M Sell
36,181
-22,140
-38% -$1.06M 0.3% 54
2021
Q4 		$3.57M Sell
58,321
-19,257
-25% -$1.33M 0.59% 47
2021
Q3 		$5.8M Buy
77,578
+18,492
+31% +$1.55M 1.09% 36
2021
Q2 		$5.46M Sell
59,086
-2,074
-3% -$176K 1.04% 37
2021
Q1 		$5.43M Buy
61,160
+46,986
+331% +$4.66M 1.15% 37
2020
Q4 		$1.32M Buy
14,174
+4,078
+40% +$325K 0.33% 45
2020
Q3 		$643K Buy
10,096
+2,863
+40% +$168K 0.19% 57
2020
Q2 		$377K Buy
+7,233
New +$310K 0.13% 66

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

McGuire Investment Group's ARKG Position: Q2 2026 in Review

McGuire Investment Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 20,491 shares — an estimated $541K sold.

McGuire Investment Group first reported a position in ARKG in Q2 2020 and held it in 24 quarters. The position peaked at $5.8M in Q3 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • McGuire Investment Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • McGuire Investment Group sold 20,491 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $541K.
  • McGuire Investment Group first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 24 quarters.
  • McGuire Investment Group's ARK Genomic Revolution ETF position peaked at $5.8M in Q3 2021.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on McGuire Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.